Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.005 USD | -8.79% |
|
-6.60% | 0.00% |
Jul. 03 | HC Wainwright Initiates Kyverna Therapeutics at Neutral With $8 Price Target | MT |
Jul. 01 | Kyverna Therapeutics, Inc.(NasdaqGS:KYTX) added to Russell Small Cap Comp Value Index | CI |
Business Summary
Number of employees: 100
Managers
Managers | Title | Age | Since |
---|---|---|---|
Peter Maag
CEO | Chief Executive Officer | 57 | 22-10-12 |
Ryan Jones
DFI | Director of Finance/CFO | 36 | 17-12-31 |
Dominic Borie
CTO | Chief Tech/Sci/R&D Officer | 61 | 19-12-31 |
Portia Serame
HRO | Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Beth Seidenberg
BRD | Director/Board Member | 67 | 18-08-31 |
Ian Clark
CHM | Chairman | 62 | 21-09-14 |
Dan Spiegelman
BRD | Director/Board Member | 65 | 21-03-31 |
Fred Cohen
BRD | Director/Board Member | 67 | 17-12-31 |
Peter Maag
CEO | Chief Executive Officer | 57 | 22-10-12 |
Brian Kotzin
BRD | Director/Board Member | 74 | 19-07-31 |
Dominic Borie
CTO | Chief Tech/Sci/R&D Officer | 61 | 19-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 43,115,244 | 38,471,716 ( 89.23 %) | 0 | 89.23 % |
Company contact information
![address Kyverna Therapeutics, Inc.(KYTX)](https://cdn.zonebourse.com/static/address/165482092.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 331M | |
+18.97% | 44.44B | |
+41.98% | 40.03B | |
-10.06% | 37.68B | |
+31.15% | 31.46B | |
-7.79% | 27.29B | |
+13.32% | 26.29B | |
+43.05% | 13.8B | |
+31.28% | 12.46B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- KYTX Stock
- Company Kyverna Therapeutics, Inc.